CLDN1 and pancreatic neoplasm: To examine the significance of Cldn1 expression in pancreatic cancer cells for malignancy, we established PK45H cells, which are poorly differentiated pancreatic cancer cells, utilizing a CRISPR/Cas9-based method for the stable knockout of Cldn1.